Up to date with medac

The challenge of inspecting injectable products has grown significantly in recent years. The future of sterile manufacturing will depend on systems capable of combining speed, precision, automation, and data intelligence into a unified quality strategy.

As lyophilization becomes increasingly important for modern biologics and complex formulations, the industry is paying closer attention to the factors that drive consistency, stability, and manufacturability. One of the most decisive of these factors — and one that is still widely misunderstood — is ice nucleation, the moment when a liquid first forms ice crystals during the freezing stage of freeze-drying.

As outsourcing strategies evolve, drug developers are increasingly seeking manufacturing partners that can offer not only capacity, but also flexibility, speed, and risk mitigation. One of the most important enablers of this shift is the growing use of single-use systems (SUS) in sterile manufacturing.